174 related articles for article (PubMed ID: 33333865)
1. Novel Isoniazid-Carborane Hybrids Active in Vitro Against
Różycka D; Korycka-Machała M; Żaczek A; Dziadek J; Gurda D; Orlicka-Płocka M; Wyszko E; Biniek-Antosiak K; Rypniewski W; Olejniczak AB
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33333865
[TBL] [Abstract][Full Text] [Related]
2. Unfairly forgotten member of the iodocarborane family: synthesis and structural characterization of 8-iodo-1,2-dicarba-closo-dodecaborane, its precursors, and derivatives.
Safronov AV; Sevryugina YV; Jalisatgi SS; Kennedy RD; Barnes CL; Hawthorne MF
Inorg Chem; 2012 Feb; 51(4):2629-37. PubMed ID: 22296243
[TBL] [Abstract][Full Text] [Related]
3. Novel iodinated carboranes: synthesis of the 8-iodo-7,9-dicarba-nido-undecaborate anion and 2-iodo-1,7-dicarba-closo-dodecaborane.
Safronov AV; Kabytaev KZ; Jalisatgi SS; Hawthorne MF
Dalton Trans; 2014 Sep; 43(33):12467-9. PubMed ID: 24782077
[TBL] [Abstract][Full Text] [Related]
4. Anti-mycobacterial activity of thymine derivatives bearing boron clusters.
Adamska A; Rumijowska-Galewicz A; Ruszczynska A; Studzińska M; Jabłońska A; Paradowska E; Bulska E; Munier-Lehmann H; Dziadek J; Leśnikowski ZJ; Olejniczak AB
Eur J Med Chem; 2016 Oct; 121():71-81. PubMed ID: 27236064
[TBL] [Abstract][Full Text] [Related]
5. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
[TBL] [Abstract][Full Text] [Related]
6. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
Genady AR
Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
8. Insight into lipophilicity of deoxyribonucleoside‑boron cluster conjugates.
Dąbrowska A; Matuszewski M; Zwoliński K; Ignaczak A; Olejniczak AB
Eur J Pharm Sci; 2018 Jan; 111():226-237. PubMed ID: 28986193
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and reactivity of 4,5-[1,2-dicarba-closo-dodecaborano(12)]-1,3-diselenacyclopentane: opening of the icosahedron to give a zwitterionic intermediate and conversion into 7,8-dicarba-nido-undecaborate(1-).
Wrackmeyer B; Klimkina EV; Milius W; Bauer T; Kempe R
Chemistry; 2011 Mar; 17(11):3238-51. PubMed ID: 21308806
[TBL] [Abstract][Full Text] [Related]
10. Dicarba-closo-dodecaborane(12) derivatives of phosphonium salts: easy formation of nido-carborane phosphonium zwitterions.
Ioppolo JA; Clegg JK; Rendina LM
Dalton Trans; 2007 May; (20):1982-5. PubMed ID: 17502929
[TBL] [Abstract][Full Text] [Related]
11. Novel approach to aminocarboranes by mild amidation of selected iodo-carboranes.
Sevryugina Y; Julius RL; Hawthorne MF
Inorg Chem; 2010 Nov; 49(22):10627-34. PubMed ID: 20964311
[TBL] [Abstract][Full Text] [Related]
12. (2,2':6',2' '-Terpyridine)platinum(II) complexes containing (thioalkyl)dicarba-closo-dodecaborane(12) ligands.
Todd JA; Turner P; Ziolkowski EJ; Rendina LM
Inorg Chem; 2005 Sep; 44(18):6401-8. PubMed ID: 16124820
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of structural patterns and luminescent properties of silver-DAFO complexes with carborane- versus "classical"-diphosphanes.
Crespo O; Gimeno MC; Laguna A; Marriott R; Sáez-Rocher JM; Villacampa MD
Dalton Trans; 2014 Aug; 43(32):12214-20. PubMed ID: 24954751
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of novel
Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
[TBL] [Abstract][Full Text] [Related]
15. Insights on the Mechanism of Action of INH-C
Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
[TBL] [Abstract][Full Text] [Related]
16. Dicarba-closo-dodecaboranes as a pharmacophore. Novel potent retinoidal agonists.
Endo Y; Iijima T; Kagechika H; Ohta K; Kawachi E; Shudo K
Chem Pharm Bull (Tokyo); 1999 Apr; 47(4):585-7. PubMed ID: 10319433
[TBL] [Abstract][Full Text] [Related]
17. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
Ma L; Hamdi J; Wong F; Hawthorne MF
Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
[TBL] [Abstract][Full Text] [Related]
18. Sterically hindered and robust pnictogen ligands derived from carboranes: synthesis and X-ray structure determination of tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))phosphine, tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))arsine and chloro(tris(1'-methyl(1,2-dicarba-closo-dodecaboran-1-yl))phosphine)gold(I).
King AS; Ferguson G; Britten JF; Valliant JF
Inorg Chem; 2004 May; 43(11):3507-13. PubMed ID: 15154815
[TBL] [Abstract][Full Text] [Related]
19. Syntheses and reductions of C-dimesitylboryl-1,2-dicarba-closo-dodecaboranes.
Kahlert J; Böhling L; Brockhinke A; Stammler HG; Neumann B; Rendina LM; Low PJ; Weber L; Fox MA
Dalton Trans; 2015 Jun; 44(21):9766-81. PubMed ID: 25939355
[TBL] [Abstract][Full Text] [Related]
20. Two isostructural carboranes: 3-phenyl-1,2-dicarba-closo-dodecaborane(12) and 1-phenyl-1,7-dicarba-closo-dodecaborane(12).
Grintselev-Knyazev GV; Lyssenko KA; Antipin MY; Knyazev SP; Kirin VN; Chernyshev EA
Acta Crystallogr C; 2001 Jul; 57(Pt 7):827-9. PubMed ID: 11443255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
